Rhinocerebral mucormycosis (RCM) is an aggressive fungal infection with a high mortality rate. It frequently develops in patients with uncontrolled diabetes mellitus or immunocompromised patients. RCM typically presents in a rapidly fulminant manner with headache, fever, mucosal necrosis, and ophthalmic symptoms. Although the definitive diagnosis is achieved by histopathological examination, computed tomography (CT) scanning and magnetic resonance (MR) are the best imaging procedures in early diagnosis to assess the extent of the disease.
Del Valle ZapicoA., Rubio SuarezA., Mellado EncinasP.Mucormycosis of the sphenoid sinus in an otherwise healthy patient. Case report and literature review.J Laryngol Otol110: 471–473, 1996.
3.
AnandV.K., AlemarG., and GriswoldJ.A.J.Intracranial complications of mucormycosis: an experimental model and clinical review.Laryngoscope102: 656–662, 1992.
4.
CutsemJ.V., and BoelaretJ.R.Effects of deferoxamine, feroxamine and iron on experimental mucormycosis (Zygomycosis).Kidney Int36: 1061–1068, 1989.
5.
WeprinB.E., HallW.A., GoodmanJ.Long term survival in rhinocerebral mucormycosis. Case report.J Neurosurgery88: 570–575, 1998.
6.
VolinoF., GiustinianiB., RussomandoC.Long-term survival in rhinocerebral mucormycosis: Case report.Acta Otorhinolaryngol Ital16: 375–379, 1996.
7.
SponslerT.A., SassaniJ.W., JohansonL.N.Ocular invasion in mucormycosis.Surv Ophthalmol36: 345–350, 1992.
8.
ZinreichS.J., KennedyD.W., MalataJ.Fungal sinusitis: diagnosis with CT and MR imaging.Radiology169: 439–444, 1988.
9.
SaydamL., ErpekG., and KizilayA.Calcified mucor fungus ball of sphenoid sinus: an unusual presentation of sinoorbital mucormycosis.Ann Otol Rhinol Laryngol106: 875–877, 1997.
10.
TierneyM.R., and BakerA.S.Infections of the head and neck in diabetes mellitus.Infect Dis Clin North Am9: 195–216, 1995.
11.
AlderD.E., MilhoratT.H., and MillerJ.I.Treatment of rhinocerebral mucormycosis with i.v., interstitial, and cerebrospinal fluid administration of amphotericin B: case report.Neurosurgery42: 644–648, 1998.
12.
MeyerR.D.Current role of therapy with amphotericin B.Clin Infect Dis14(suppl. 1): 5154–5160, 1992.
13.
StrasserM.D., KennedyR.J., and AdamR.D.Rhinocerebral mucormycosis. Therapy with amphotericin B lipid complex.Arch Intern Med156: 337–339, 1996 (Comment).
14.
FisherE.W., TomaA., FisherP.H.Rhinocerebral mucormycosis: use of liposomal amphotericin B.J Laryngol Otol105: 575–577, 1991.
15.
BlitzerA., LowaonW., MeyerB.R., and BillerH.F.Patient survival factors in paranasal sinus mucormycosis.Laryngoscope90: 635–648, 1980.
16.
RajP., VellaE.J., and BickertonR.C.Successful treatment of rhinocerebral mucormycosis by a combination of aggressive surgical débridement and the use of systemic liposomal amphotericin B and local therapy with nebulized amphotericin: a case report.J Laryngol Otol112: 367–370, 1998.
17.
AvetP.P., KlineL.B., and SillersM.J.Endoscopic sinus surgery in the managment of mucomycosis.J Neuroophtalmol19: 56–61, 1999.
18.
JianyR.S., and HsuC.Y.Endoscopic sinus surgery for rhinocerebral mucormycosis.Am J Rhinol13: 105–109, 1999.
19.
PetersonK.L., WangM., CanalisR.F.Rhinocerebral mucormycosis: evolution of the disease and treatment options.Laryngoscope107: 855–862, 1997.
